• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Case Report of a Successful Treatment of Ipilimumab Plus Nivolumab (IPI-NIVO)-Induced Sialadenitis with Coconut Oil.

作者信息

Slaymaker Colin P, Doolittle Gary C

机构信息

Department of Medical Oncology, University of Kansas School of Medicine-Wichita, Wichita, KS.

Department of Medical Oncology, University of Kansas School of Medicine-Kansas City, Kansas City, KS.

出版信息

Kans J Med. 2024 Sep 5;17(5):103-104. doi: 10.17161/kjm.vol17.22394. eCollection 2024 Sep-Oct.

DOI:10.17161/kjm.vol17.22394
PMID:39758550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11698237/
Abstract
摘要

相似文献

1
A Case Report of a Successful Treatment of Ipilimumab Plus Nivolumab (IPI-NIVO)-Induced Sialadenitis with Coconut Oil.椰子油成功治疗伊匹木单抗联合纳武单抗（IPI-NIVO）诱发的涎腺炎1例报告
Kans J Med. 2024 Sep 5;17(5):103-104. doi: 10.17161/kjm.vol17.22394. eCollection 2024 Sep-Oct.
2
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial.纳武利尤单抗联合伊匹单抗对比舒尼替尼用于晚期肾细胞癌患者的生存结局和独立应答评估：一项随机 3 期临床试验的 42 个月随访结果。
J Immunother Cancer. 2020 Jul;8(2). doi: 10.1136/jitc-2020-000891.
3
Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up.纳武利尤单抗联合伊匹单抗对比舒尼替尼用于既往未治疗的晚期肾细胞癌：CheckMate 214 研究中日本患者的分析结果，随访时间延长。
Jpn J Clin Oncol. 2020 Jan 24;50(1):12-19. doi: 10.1093/jjco/hyz132.
4
A matching-adjusted indirect comparison of combination nivolumab plus ipilimumab with BRAF plus MEK inhibitors for the treatment of BRAF-mutant advanced melanoma.对比纳武利尤单抗联合伊匹单抗与 BRAF 及 MEK 抑制剂治疗 BRAF 突变型晚期黑色素瘤的匹配调整间接比较。
ESMO Open. 2021 Apr;6(2):100050. doi: 10.1016/j.esmoop.2021.100050. Epub 2021 Feb 6.
5
Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab.先前接受过伊匹单抗/纳武单抗治疗的黑色素瘤患者再次使用伊匹单抗/纳武单抗的风险和获益。
J Immunother Cancer. 2021 Oct;9(10). doi: 10.1136/jitc-2021-003395.
6
Re-exposition to ipilimumab plus nivolumab in metastatic Merkel cell carcinoma.转移性默克尔细胞癌中再次使用伊匹木单抗联合纳武单抗治疗。
Front Immunol. 2024 Dec 5;15:1495004. doi: 10.3389/fimmu.2024.1495004. eCollection 2024.
7
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial.纳武利尤单抗联合伊匹木单抗与舒尼替尼一线治疗晚期肾细胞癌：III期CheckMate 214试验的4年延长随访
ESMO Open. 2020 Nov;5(6):e001079. doi: 10.1136/esmoopen-2020-001079.
8
Adverse Events of Cabozantinib Plus Nivolumab Versus Ipilimumab Plus Nivolumab.卡博替尼联合纳武单抗与伊匹单抗联合纳武单抗的不良事件
Clin Genitourin Cancer. 2024 Feb;22(1):e122-e127.e1. doi: 10.1016/j.clgc.2023.09.003. Epub 2023 Sep 18.
9
First-line Nivolumab plus Ipilimumab Versus Sunitinib in Patients Without Nephrectomy and With an Evaluable Primary Renal Tumor in the CheckMate 214 Trial.CheckMate 214 试验中未经肾切除术且可评估主要肾脏肿瘤患者的一线纳武利尤单抗联合伊匹木单抗与舒尼替尼比较。
Eur Urol. 2022 Mar;81(3):266-271. doi: 10.1016/j.eururo.2021.10.001. Epub 2021 Nov 5.
10
Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trial.纳武利尤单抗联合瑞派利单抗及纳武利尤单抗联合伊匹木单抗治疗晚期肾细胞癌患者：开放标签、随机、II期FRACTION-RCC试验结果
ESMO Open. 2024 Dec;9(12):104073. doi: 10.1016/j.esmoop.2024.104073. Epub 2024 Dec 5.

本文引用的文献

1
"Cancer's a demon": a qualitative study of fear and multilevel factors contributing to cancer treatment delays.“癌症是个恶魔”：一项定性研究，探讨了导致癌症治疗延误的恐惧及多层次因素。
Support Care Cancer. 2023 Dec 7;32(1):13. doi: 10.1007/s00520-023-08200-9.
2
Microbiological Effects of Virgin Coconut Oil Pulling in Comparison with Palm Oil Pulling as an Adjunctive Oral Hygiene Care for Patients with Gingival Inflammation: A Randomized Controlled Clinical Trial.初榨椰子油拉舌法与棕榈油拉舌法对牙龈炎症患者辅助口腔卫生护理的微生物学影响：一项随机对照临床试验
J Indian Soc Periodontol. 2022 Jan-Feb;26(1):58-63. doi: 10.4103/jisp.jisp_768_20. Epub 2021 Sep 27.
3
The effect of oil pulling with coconut oil to improve dental hygiene and oral health: A systematic review.
用椰子油进行油拔法对改善口腔卫生和口腔健康的影响：一项系统评价。
Heliyon. 2020 Aug 27;6(8):e04789. doi: 10.1016/j.heliyon.2020.e04789. eCollection 2020 Aug.
4
Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy.干燥综合征与免疫检查点抑制剂治疗相关。
Oncologist. 2019 Sep;24(9):1259-1269. doi: 10.1634/theoncologist.2018-0823. Epub 2019 Apr 17.
5
Nivolumab and ipilimumab: immunotherapy for treatment of malignant melanoma.尼妥珠单抗联合西妥昔单抗：免疫治疗恶性黑色素瘤。
Future Oncol. 2019 Feb;15(4):349-358. doi: 10.2217/fon-2018-0607. Epub 2018 Oct 18.
6
Nivolumab-induced sialadenitis.纳武单抗诱发的涎腺炎。
Respirol Case Rep. 2018 Apr 15;6(5):e00322. doi: 10.1002/rcr2.322. eCollection 2018 Jul.
7
Releasing the brake on the immune system: ipilimumab in melanoma and other tumors.释放免疫系统的刹车：伊匹单抗在黑色素瘤和其他肿瘤中的应用。
Cancer Biother Radiopharm. 2010 Dec;25(6):601-13. doi: 10.1089/cbr.2010.0865.